An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants
Ya-ting Zheng, Xian-zhu Jin, Chuan-jian Zhang, Sai-sai Chen, Nikolaus Osterrieder, Ya-mei Liu, Ji-chun Wang · 2026
Read An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants by Ya-ting Zheng, Xian-zhu Jin, Chuan-jian Zhang, Sai-sai Chen, Nikolaus Osterrieder, Ya-mei Liu, Ji-chun Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634121.txt.
Description
Ya-ting Zheng and six co-authors test a new pig vaccine in a 2026 paper. The target virus causes heavy losses in piglets and breeding failures in China, and newer strains have spread for over a decade. Standard oil-based vaccines work but often cause local reactions. A water-based additive offers a safer option with strong immune effects.
Their killed-virus vaccine paired that additive with a booster ingredient chosen from several candidates. In mice it gave strong protection after two doses. In piglets, shots into muscle produced higher antibody levels than the control vaccines and full survival after challenge, with less virus shedding. Shots into skin worked less well.
Catalog record
| CREATOR | Ya-ting Zheng, Xian-zhu Jin, Chuan-jian Zhang, Sai-sai Chen, Nikolaus Osterrieder, Ya-mei Liu, Ji-chun Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |